Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/376"
Predicate | Value (sorted: default) |
---|---|
rdfs:label | |
rdf:type | |
?:Evidence_enzyme_system | |
?:Evidence_type | |
?:content |
"The FDA recommends theophylline to be an acceptable chemical CYP1A2 substrate (theophylline N-demethylation) for in vitro experiments in it most recent guidance document. See Table 3, p. 32"
|
dc:creator | |
dc:date |
"06/20/2009 11:58:32"
|
rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ theophylline_in_vitro_probe_substrate_of_enzyme_cyp1a2, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1007 }